S
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
Price:
37.25
CNY
-0.69%
Market Closed
Market Cap:
¥15.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
|
CN |
|
C
|
Chykingyoung Investment Development Holdings Inc
OTC:CHYI
|
CA |
|
Blusky AI Inc
OTC:BSAI
|
US |
|
Taitron Components Inc
NASDAQ:TAIT
|
US |
|
S
|
Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
|
CN |
|
I
|
Incheon City Gas Co Ltd
KRX:034590
|
KR |
|
B
|
Bytetravel SA
MAD:SCBYT
|
ES |
Cash Flow Statement
Cash Flow Statement
Shandong Weigao Blood Purification Products Co Ltd
Shandong Weigao Blood Purification Products Co Ltd
Currency: CNY
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Stock-Based Compensation |
53
|
27
|
11
|
|
| Cash Taxes Paid |
(203)
|
(302)
|
(343)
|
|
| Change in Working Capital |
(996)
|
(1 148)
|
(1 020)
|
|
| Cash from Operating Activities |
727
N/A
|
288
-60%
|
572
+99%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(280)
|
(233)
|
(179)
|
|
| Other Items |
38
|
45
|
(200)
|
|
| Cash from Investing Activities |
(242)
N/A
|
(188)
+23%
|
(379)
-102%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
624
|
0
|
0
|
|
| Net Issuance of Debt |
(758)
|
(35)
|
3
|
|
| Other |
(88)
|
(12)
|
(19)
|
|
| Cash from Financing Activities |
(222)
N/A
|
(47)
+79%
|
(15)
+67%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
3
|
1
|
(1)
|
|
| Net Change in Cash |
266
N/A
|
54
-80%
|
177
+227%
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
448
N/A
|
55
-88%
|
393
+610%
|
|
Switch to:
Switch to:
See Also
Discover More
